All In Biotech

Drug Trial Radar · NCT04892706

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel (0.3% Adapalene/2.5% BPO), in the Treatment of Acne Vulgaris

Last checked: Nov 20, 2026Latest source record: Oct 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 686 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

686

Actual

Start

Jun 11, 2021

Primary completion

Sep 28, 2022

Study completion Sep 28, 2022

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
May 19, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 99 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The safety and efficacy of once daily application of IDP 126 Gel will be compared to Epiduo® Forte and IDP-126 Vehicle Gel.

Conditions

  • Acne Vulgaris

Interventions

  • IDP-126 GelDrug

    Gel applied to face once daily in the evening.

  • IDP-126 Vehicle GelDrug

    Gel applied to face once daily in the evening.

  • Epiduo® Forte GelDrug

    Gel applied to face once daily in the evening.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute Change From Baseline to Week 12 in Lesion Counts.Time frame: Baseline to Week 12
  2. Percentage of Subjects Who Achieve at Least a Two-grade Reduction From Baseline and Are "Clear" or "Almost Clear" at Week 12 in the Evaluator's Global Severity Score.Time frame: Baseline to Week 12

Locations

42 sites in 3 countries. Site status is shown where the registry gives one.

  • Bausch Site 134

    Bryant, Arkansas

  • Bausch Site 118

    Rogers, Arkansas

  • Bausch Site 110

    Fremont, California

  • Bausch Site 101

    Manhattan Beach, California

  • Bausch Site 106

    San Diego, California

  • Bausch Site 112

    San Diego, California

  • Bausch Site 128

    San Diego, California

  • Bausch Site 105

    Boynton Beach, Florida

  • Bausch Site 126

    Clearwater, Florida

  • Bausch Site 135

    North Miami Beach, Florida

  • Bausch Site 143

    Sanford, Florida

  • Bausch Site 102

    Tampa, Florida

  • Bausch Site 104

    West Palm Beach, Florida

  • Bausch Site 122

    West Palm Beach, Florida

  • Bausch Site 124

    Newnan, Georgia

  • Bausch Site 127

    Boise, Idaho

  • Bausch Site 129

    Louisville, Kentucky

  • Bausch Site 139

    Mandeville, Louisiana

  • Bausch Site 121

    Metairie, Louisiana

  • Bausch Site 116

    Rockville, Maryland

  • Bausch Site 103

    Brighton, Massachusetts

  • Bausch Site 120

    New Brighton, Minnesota

  • Bausch Site 108

    Las Vegas, Nevada

  • Bausch Site 119

    New York, New York

  • Bausch Site 133

    New York, New York

  • Bausch Site 142

    High Point, North Carolina

  • Bausch Site 109

    Dublin, Ohio

  • Bausch Site 117

    Oklahoma City, Oklahoma

  • Bausch Site 107

    Gresham, Oregon

  • Bausch Site 114

    Nashville, Tennessee

  • Bausch Site 111

    Austin, Texas

  • Bausch Site 132

    Houston, Texas

  • Bausch Site 123

    Pflugerville, Texas

  • Bausch Site 137

    Spokane, Washington

  • Bausch Site 136

    Kortrijk, Belgium

  • Bausch Site 140

    Maldegem, Belgium

  • Bausch Site 138

    Winnipeg, Manitoba, Canada

  • Bausch Site 125

    Markham, Ontario, Canada

  • Bausch Site 141

    Oakville, Ontario, Canada

  • Bausch Site 115

    Peterborough, Ontario, Canada

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.